Insuman Comb 25

Insulin Human, the active ingredient in Insuman Comb 25, is a short‑acting insulin presented as an injectable solution for subcutaneous administration. It mimics natural pancreatic insulin to lower blood glucose levels and is used in the management of type 1 and type 2 diabetes mellitus in adults and children.

GNH USA supplies Insuman Comb 25 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Insuman Comb 25, a human insulin analogue, is used to control blood glucose in diabetes mellitus.

- Type 1 diabetes mellitus: provides basal and prandial insulin coverage to achieve glycemic control. - Type 2 diabetes mellitus: added when oral agents are insufficient to maintain target glucose levels.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase in body weight due to improved glucose utilization. - Lipodystrophy: localized changes in fat tissue with repeated injections. - Edema: mild fluid retention, particularly in the lower extremities. - Headache: transient mild headache after injection.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hypoglycemia: prolonged low blood glucose that may cause loss of consciousness. - Hypokalemia: low serum potassium levels, potentially leading to cardiac arrhythmias. - Insulin antibodies: formation of antibodies that may alter insulin action. - Acute insulin edema: rapid fluid accumulation causing swelling and shortness of breath. - Necrotizing fasciitis: extremely rare but serious soft‑tissue infection at injection sites.

Insuman Comb 25 requires careful clinical monitoring and patient education.

- Blood glucose monitoring: frequent checks are essential to adjust dose and avoid hypoglycemia. - Dose adjustment during illness: illness, fever or reduced food intake may necessitate dose changes. - Renal or hepatic impairment: use with caution as clearance may be altered. - Avoid use during hypoglycemia: do not administer if blood glucose is already low. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Comb 25 may interact with several drug classes.

Major Interactions (Avoid): - Other insulin products: additive hypoglycemic effect. - Sulfonylureas: increased risk of severe hypoglycemia. - Meglitinides: potentiates hypoglycemic action. - Alcohol: can enhance insulin’s glucose‑lowering effect.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose levels. - Corticosteroids: can increase insulin requirements. - Beta‑adrenergic agonists: may blunt hypoglycemia warning signs. - Beta‑blockers: can mask symptoms of hypoglycemia. - ACE inhibitors: may potentiate insulin’s glucose‑lowering effect.